New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

CVS Health Corporation

CVS

Healthcare Healthcare Plans

CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024.

Revenue
+5.37%
EPS
n/m
Free cash flow
+3,886.7%
Total debt
−7.83%

Quarter to September 2026, against a year earlier

80.05 1.30 −1.60%

After hours trading: 80.05, unchanged, last trade Thu 7:55pm Eastern.

Market cap
$102.4B
P/E
9.2×
Fwd P/E FY26e
12.8×
Dividend yield
3.32%
F-score
7/9
ROIC
7.44%
Net debt / EBITDA
3.6×
Payout ratio
0.3×

CVS Health Corporation (CVS) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2025: revenue by segment, and margins
Health Services 190,425 47.36%
Health Care Benefits 143,354 35.65%
Pharmacy & Consumer Wellness 139,367 34.66%
Gross margin 44.99%
Operating margin 1.16%
Pre-tax margin 0.53%

Revenue by product or service $m

Line FY2018 FY2017 FY2016
Products 183,910 180,063 173,377
Services 1,825 1,144 1,080
Premiums — — 3,069
Other, not broken out 8,844 3,579 —
Revenue 194,579 184,786 177,526

Revenue by segment $m

Line FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009 FY2008
Health Services 190,425 173,605 186,843 169,576 153,892 — — — — — — — — — — — — —
Health Care Benefits 143,354 130,665 105,646 91,350 82,119 75,467 69,604 8,962 3,587 0 — — — — — — — —
Pharmacy & Consumer Wellness 139,367 124,500 116,763 108,596 101,620 — — — — — — — — — — — — —
Pharmacy Services — — — — — 141,938 141,491 134,736 130,822 119,963 100,363 88,440 76,208 73,444 58,874 47,145 50,551 43,769
Retail Long-Term Care — — — — — 91,198 86,608 83,989 79,398 81,100 72,007 67,798 65,618 63,641 59,579 57,345 55,355 48,990
Corporate and Other — — — — — — — — 16 0 — — — — — — — —
Corporate — — — — — — — — — — — 0 0 0 0 — — —
Intersegment Eliminations — — — — — — — — — — — — — (13,965) (11,373) (8,712) (7,691) (5,287)
Eliminations (71,079) (55,961) (51,476) (47,055) (45,520) (39,897) (40,927) (33,108) (29,037) (23,537) (19,080) (16,871) (15,065) — — — — —
Revenue 402,067 372,809 357,776 322,467 292,111 268,706 256,776 194,579 184,786 177,526 153,290 139,367 126,761 123,120 107,080 95,778 98,215 87,472

Operating income by segment $m, and margin

Operating figures as reported in each quarter’s results release or filing

Figure Quarter Latest A year before Change
Commercial medical membership Q3 FY2026 18.4M 18.9M −2.37%
Days Claims Payable Q3 FY2026 41.90 42.50 −1.41%
Medicaid medical membership Q3 FY2026 2.3M 2.4M −1.82%
Medicare Advantage medical membership Q3 FY2026 4.2M 4.3M −0.87%
Medicare Prescription Drug Plan (standalone) Q3 FY2026 3.9M 4.1M −4.88%
Medicare Supplement medical membership Q3 FY2026 1.2M 1.2M −4.67%
People served through health insurance products and related services Q3 FY2026 37.0M 37.0M 0.00%
Pharmacy benefits manager plan members Q3 FY2026 87.0M 87.0M 0.00%
Pharmacy claims processed Q3 FY2026 481.7M 475.6M +1.28%
Prescriptions filled Q3 FY2026 470.0M 461.4M +1.86%
Retail pharmacy locations Q3 FY2026 9.0K 9.0K 0.00%
Total medical membership Q3 FY2026 26.1M 26.7M −2.18%
Walk-in and primary care medical clinics Q3 FY2026 1.0K 1.0K 0.00%

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.